Frank Verwiel, MD

Frank Verwiel served as President, Chief Executive Officer and a board member of Aptalis Pharma, Inc., a privately-held, specialty pharmaceutical company, which was acquired by Forest Laboratories, Inc. (now Allergan Inc.) in 2014. Previously, Frank held international senior management positions with Merck & Co., Inc. and Servier Laboratories SA.

Frank serves as a board member of Achillion Inc., Bavarian Nordic A/S and Intellia Inc. He was a board member of InterMune, Inc. until it was acquired by Roche in 2014 and Avexis Inc. until it was acquired by Novartis in 2018.. Frank was also a board member of the Biotechnology Industry Organisation (BIO).

Frank holds an MD from Erasmus University, Rotterdam in The Netherlands and an MBA from INSEAD, Fontainebleau in France.

Leave a Reply

Your email address will not be published. Required fields are marked *

Are you sure you want to leave ObsEva.com?

We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

Continue to link

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue